MEDAX | MEDBX | MEDAX / MEDBX | |
Total Expense Ratio | 1.06 | 1.81 | 59% |
Annual Report Gross Expense Ratio | 1.07 | 1.82 | 59% |
Fund Existence | 27 years | 23 years | - |
Gain YTD | -1.889 | -2.057 | 92% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.75B | 6.75B | 100% |
Annual Yield % from dividends | 6.52 | 5.76 | 113% |
Returns for 1 year | 3.85 | 3.09 | 125% |
Returns for 3 years | 9.43 | 7.04 | 134% |
Returns for 5 years | 15.13 | 10.93 | 138% |
Returns for 10 years | 26.71 | 17.55 | 152% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WINIX | 9.26 | 0.24 | +2.66% |
Wilmington International Institutional | |||
GLCTX | 25.70 | 0.50 | +1.98% |
Goldman Sachs Large Cap Gr Insghts Inv | |||
TWCIX | 106.02 | 1.93 | +1.85% |
American Century Select Inv | |||
DHPAX | 15.54 | 0.27 | +1.77% |
Diamond Hill Mid Cap Inv | |||
MRJCX | 10.26 | 0.09 | +0.88% |
Morgan Stanley Multi-Asset Real Return C |